![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Lauer-Fields J.L. Fields G.B.
Publisher: Informa Healthcare
ISSN: 1354-3776
Source: Expert Opinion on Therapeutic Patents, Vol.10, Iss.12, 2000-12, pp. : 1873-1884
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Selective Matrix Metalloproteinase Inhibitors for Cancer
Current Medicinal Chemistry, Vol. 16, Iss. 29, 2009-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Matrix metalloproteinase inhibitors
Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 10, 1997-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Matrix metalloproteinase inhibitors 1998
Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 3, 1998-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Ongoing trials with matrix metalloproteinase inhibitors
By Brown P.D.
Expert Opinion on Investigational Drugs, Vol. 9, Iss. 9, 2000-09 ,pp. :